J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 7.13 CNY -0.14% Market Closed
Market Cap: 8B CNY
Have any thoughts about
Jinyu Bio-Technology Co Ltd?
Write Note
Jinyu Bio-Technology Co Ltd
/
Balance Sheet
/
Accounts Receivables

Jinyu Bio-Technology Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinyu Bio-Technology Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
J
Jinyu Bio-Technology Co Ltd
SSE:600201
Accounts Receivables
¥694.8m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Beigene Ltd
HKEX:6160
Accounts Receivables
¥2.5B
CAGR 3-Years
86%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Accounts Receivables
¥1.4B
CAGR 3-Years
11%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accounts Receivables
¥3B
CAGR 3-Years
63%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accounts Receivables
¥25.5B
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
50%
Imeik Technology Development Co Ltd
SZSE:300896
Accounts Receivables
¥206.1m
CAGR 3-Years
91%
CAGR 5-Years
87%
CAGR 10-Years
N/A
No Stocks Found

Jinyu Bio-Technology Co Ltd
Glance View

Market Cap
8B CNY
Industry
Biotechnology

Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.

Intrinsic Value
10.74 CNY
Undervaluation 34%
Intrinsic Value
Price
J
What is Intrinsic Value?

See Also

What is Jinyu Bio-Technology Co Ltd's Accounts Receivables?
Accounts Receivables
694.8m CNY

Based on the financial report for Sep 30, 2024, Jinyu Bio-Technology Co Ltd's Accounts Receivables amounts to 694.8m CNY.

What is Jinyu Bio-Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
8%

Over the last year, the Accounts Receivables growth was -25%. The average annual Accounts Receivables growth rates for Jinyu Bio-Technology Co Ltd have been -5% over the past three years , -1% over the past five years , and 8% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.